[1]
“Treatment of Spasticity Due to Multiple Sclerosis with Sativex®: Who Benefits Most? Three Case Reports”, acmcr, vol. 5, no. 2, pp. 287–290, Mar. 2021, Accessed: Sep. 11, 2026. Available: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22477